Michael Studnicka
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Diagnosis and Treatment
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 30
- Lung Cancer Diagnosis and Treatment 21
- Lung Cancer Treatments and Mutations 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Occupational and environmental lung diseases 3
-
- Cardiovascular and exercise physiology 3
- Co-authors
- Sylvia Hartl (12 shared papers)Bernhard Kaiser (9 shared papers)Bernd Lamprecht (16 shared papers)Peter Porsch (7 shared papers)Francisco Pozo-Rodrı́guez (1 shared paper)José Luís López-Campos (1 shared paper)Christopher Michael Roberts (1 shared paper)Ady Angélica Castro-Acosta (1 shared paper)
- Journals
- Respiratory Medicine (6 papers)Respiratory Research (6 papers)American Journal of Respiratory and Critical Care Medicine (5 papers)Strahlentherapie und Onkologie (4 papers)Scientific Reports (3 papers)
- Partner nations
- AustriaGermanyNetherlands
In The Last Decade
Michael Studnicka
79 papers receiving 4.3k citations
Michael Studnicka's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.6k
- Physiology 213
- Immunology 153
- Radiation 50
Countries citing papers authored by Michael Studnicka
This map shows the geographic impact of Michael Studnicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Studnicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Studnicka more than expected).
Fields of papers citing papers by Michael Studnicka
This network shows the impact of papers produced by Michael Studnicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Studnicka. The network helps show where Michael Studnicka may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Studnicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1737 |
| 2 | Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2020 | 522 |
| 3 | Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study Hit paper breakdown → | 2018 | 314 |
| 4 | 2015 | 193 | |
| 5 | 2011 | 174 | |
| 6 | 2020 | 136 | |
| 7 | 2016 | 112 | |
| 8 | 2012 | 82 | |
| 9 | 2020 | 79 | |
| 10 | 2018 | 75 | |
| 11 | 2008 | 74 | |
| 12 | 2020 | 58 | |
| 13 | 2018 | 54 | |
| 14 | 2020 | 38 | |
| 15 | 1995 | 35 | |
| 16 | 2020 | 30 | |
| 17 | 2022 | 28 | |
| 18 | 2020 | 25 | |
| 19 | 1995 | 24 | |
| 20 | 2019 | 21 |
About Michael Studnicka
Michael Studnicka is a scholar working on Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Oncology, Health, Toxicology and Mutagenesis and Physiology, having authored 86 papers that have together received 4.4k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cardiovascular and exercise physiology (3 papers), Asthma and respiratory diseases (3 papers), Occupational and environmental lung diseases (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.6k citations), Physiology (213 citations), Immunology (153 citations) and Radiation (50 citations). Michael Studnicka has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Sylvia Hartl, Bernhard Kaiser, Bernd Lamprecht, Peter Porsch, Francisco Pozo-Rodrı́guez, José Luís López-Campos, Christopher Michael Roberts, Ady Angélica Castro-Acosta, Otto Chris Burghuber and Christian Pirich. Their work appears in journals such as Respiratory Medicine, Respiratory Research, American Journal of Respiratory and Critical Care Medicine, Strahlentherapie und Onkologie and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.